Safety First: FDA Rejects Schering-Plough Anesthesia Reverser

In a surprise, the FDA has rejected Schering-Plough’s application to sell a drug called sugammadex, the company said. Even in today’s tough safety climate, the thumbs-down is unusual because it goes against the unanimous recommendation of outside experts to the agency that it approve the drug, the first of its kind.
The drug, which would be [...]